SLB Stock: Upgrading Back To A Buy As The Earnings Recovery Takes Shape

SLB posted Q3 revenue and EPS double beats, with sequential margin expansion in all four divisions and strength outside the Middle East. The company guides for approximately $10B in Q4 revenue despite flat Middle East activity, while 2027 EPS is projected to grow 30% year over year. The upgrade from neutral to bullish cites renewed growth momentum and valuation returning to historical norms.

Analysis

The key change is reduced dependence on Middle East activity: if strength across other regions reflects sustained customer spending rather than project timing or mix, SLB’s earnings become less exposed to a single regional capex cycle. That would support a more durable earnings multiple and could put pressure on peers with less diversified international exposure, including Halliburton and Baker Hughes. The counterpoint is that flat Middle East activity removes a potential incremental growth engine, while sequential margin improvement across divisions may prove less durable than the forward EPS narrative implies.

Near term, estimate revisions and positioning are likely to matter more than the headline beat. Over 1–3 months, watch whether SLB converts its Q4 outlook into cash generation and maintains margins as activity mix evolves. Over 6–18 months, the bullish case depends on customer budgets and pricing supporting the projected 2027 earnings path. Treat the stated return to historical valuation norms as a claim to verify against current multiples and the company’s own cycle-adjusted history—not as independent evidence of upside.

Contrarian risk: investors may capitalize a single quarter’s stabilization into a long-dated growth assumption too quickly. The thesis weakens if subsequent guidance trims the 2027 outlook, non-Middle East activity softens, or margins reverse despite revenue delivery.

Key Decisions for Investors

• Consider a staged long in SLB on post-results consolidation rather than chasing an immediate gap; add only if the next update confirms broad-based activity and margin durability.
• For a relative-value expression, consider long SLB against Halliburton or Baker Hughes only if their subsequent outlooks show weaker international demand or margins; confirm comparable valuation and exposure before sizing.
• Monitor realized cash conversion, regional activity commentary, and margin progression through the next 1–3 months. Treat revenue delivery without cash-flow or margin follow-through as a warning, not confirmation.
• Falsification triggers: a cut to the 2027 earnings outlook, renewed weakness outside the Middle East, or sequential margin deterioration despite revenue holding near guidance. Reassess rather than relying on the historical-valuation argument.